Elizabeth A. Grammer
Director · Sagimet Biosciences Inc.
- 2024
- Jun 15, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Elizabeth A. Grammer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- George Kemble - $4.22M in SGMT purchases and sales in the last 12 months
- Michael Raab - $2.57M in ARDX purchases and sales in the last 12 months
- David M. Mott - $1.95M in ARDX purchases and sales in the last 12 months
- Laura A. Williams - $659K in ARDX purchases and sales in the last 12 months
- David Happel - $562K in SGMT purchases and sales in the last 12 months
- Eric Duane Foster - $176K in ARDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Elizabeth A. Grammer?
Elizabeth A. Grammer is a corporate insider, tracked as Director of Sagimet Biosciences Inc. (SGMT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Elizabeth A. Grammer last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 6 filings going back to 2024.
Has Elizabeth A. Grammer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($126K) across all tracked filings.
